August 12, 2022

New York, New York,

EXEEVO, a global enterprise SaaS leader focused on revolutionizing healthcare professional and personalizing patient experiences for life sciences organizations, announces that the second largest Japan-based life sciences company has selected Omnipresence, Exeevo’s customer experience solution to power the growth of their Cardiovascular-Metabolic franchise in Europe building on the success of choosing Omnipresence for their Oncology franchise in 2019.

With Exeevo Omnipresence, Oncology and Cardiovascular teams can design and deliver true personalized omnichannel experiences for their life sciences customers and HCPs through shared customer journeys and powerful omnichannel capabilities. Omnipresence’s innovative digital tools provide the entire organization, including commercial, marketing, and medical affairs, the hybrid operating model they need to succeed.

Derek J. Evans, Chief Growth Officer, Exeevo, states, “We’re proud to be recognized as a trusted partner and to support our customers’ drive for better commercial strategies with a modern customer experience platform that can keep up with the pace and complexity of today’s rapidly changing healthcare landscape.”


Discover Exeevo Omnipresence here